Efficacy and Safety of TMS and Deep TMS Treatment for Psychiatric and Neurological Disorders

Sveti Ivan Psychiatric Hospital

Status: Completed

Conditions: Mood Disorders

Treatments: Device: TMS

Study type: Interventional

Funder types: Other

Identifiers

NCT02917499

TMS

Details and patient eligibility

About

The goal of this study is to examine the efficacy and safety of transcranial magnetic stimulation (TMS) and deep TMS (dTMS) for treatment of different psychiatric and neurological disorders. Subjects will be randomized into two groups: experimental (treated with pharmacotherapy and TMS) and control group (treated only with pharmacotherapy). They and their clinicians will complete a battery of instruments that measure relevant symptoms, global functioning and quality of life. The first measurement will be done after the inclusion and before treatment. The second measurement will be made immediately after the end of treatment (after 4 weeks). The other measurements (follow-up) will be made after 3 and 6 months.

Enrollment: 228 patients

Sex: All

Ages: 30 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosed psychiatric or neurological disorder, duration of disorder for at least 5 years, inpatients or outpatients treated in Psychiatric hospital Sveti Ivan

Exclusion criteria

• suicidality, psychosis, alcohol addiction, unable to complete the questionnaires

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

228 participants in 2 patient groups

TMS

Experimental group

Description:

The experimental group will be treated with transcranial magnetic stimulation for 4 weeks.

Treatment:

Device: TMS

noTMS

No Intervention group

Description:

The control (no intervention) group will be treated as usual (with pharmacotherapy). These patients will receive TMS treatment after data collection is ended.